CoChat
Sign Up
Cited by 566Workplace Health and Well-beingChronic Disease Management StrategiesOccupational Health and Safety in Workplaces

The assessment of chronic health conditions on work performance, absence, and total economic impact for employers

Collins, James J., Baase, Catherine M., Sharda, Claire E., Ozminkowski, Ronald J., Nicholson, Sean, Billotti, Gary M., Turpin, Robin S., Olson, Michael +1 more·2005·Journal of Occupational and Environmental Medicine
DOI 10.1097/01.jom.0000166864.58664.29
Open this paper in CoChat — free account

Abstract

OBJECTIVE: The objective of this study was to determine the prevalence and estimate total costs for chronic health conditions in the U.S. workforce for the Dow Chemical Company (Dow). METHODS: Using the Stanford Presenteeism Scale, information was collected from workers at five locations on work impairment and absenteeism based on self-reported "primary" chronic health conditions. Survey data were merged with employee demographics, medical and pharmaceutical claims, smoking status, biometric health risk factors, payroll records, and job type. RESULTS: Almost 65% of respondents reported having one or more of the surveyed chronic conditions. The most common were allergies, arthritis/joint pain or stiffness, and back or neck disorders. The associated absenteeism by chronic condition ranged from 0.9 to 5.9 hours in a 4-week period, and on-the-job work impairment ranged from a 17.8% to 36.4% decrement in ability to function at work. The presence of a chronic condition was the most important determinant of the reported levels of work impairment and absence after adjusting for other factors (P < 0.000). The total cost of chronic conditions was estimated to be 10.7% of the total labor costs for Dow in the United States; 6.8% was attributable to work impairment alone. CONCLUSION: For all chronic conditions studied, the cost associated with performance based work loss or "presenteeism" greatly exceeded the combined costs of absenteeism and medical treatment combined.

Integrity signals

Registry

Crossref · 10.1097/01.jom.0000166864.58664.29

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Musculoskeletal disorders and major depressive episode are associated with the highest levels of disability at the individual level among commonly occurring disorders; major depressive disorder and bipolar disorder are the mental disorders most often rated severely impairing in both developed and developing countries; none of the physical disorders considered had impairment levels as high as major

    “MDE was included in a number of these studies and the results typically showed that musculoskeletal disorders and MDE were associated with the highest levels of disability at the individual level among all commonly occurring disorders assessed. The most compelling study of this sort outside the US was based on fifteen national surveys carried out as part of the WMH surveys.82 Disorder-specific dis”

    From The Costs of Depression (2012) · cites this paper as [59]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Authors
Collins, J. J., Baase, C. M., Sharda, C. E., Ozminkowski, R. J., Nicholson, S., Billotti, G. M., Turpin, R. S., Olson, M., & Berger, M. L.
Affiliations
  • Dow Chemical (United States) (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author
Baase, Catherine M.
ORCID
Venue
Journal of Occupational and Environmental Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2005-06
Volume
47
Issue
6
Pages
547-557
ISSN
1076-2752 (ISSN-L)
DOI
10.1097/01.jom.0000166864.58664.29
OpenAlex
W1988186879
Cited by
566
References
34
Citations by year
2026: 5 · 2025: 21 · 2024: 24 · 2023: 27 · 2022: 41 · 2021: 35 · 2020: 21 · 2019: 34 · 2018: 28 · 2017: 35 · 2016: 26 · 2015: 43 · 2014: 36 · 2013: 37 · 2012: 31
FWCI
29.48
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Occupational and Environmental Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Merck
Topics
  • Health Sciences › Health Professions › General Health Professions › Workplace Health and Well-being
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
  • Health Sciences › Health Professions › Occupational Therapy › Occupational Health and Safety in Workplaces
Keywords
chronic disease, presenteeism, work impairment, absenteeism, employer costs, labor costs, occupational health, allergy, arthritis, Dow Chemical
MeSH terms
Absenteeism, Adult, Chronic Disease, Employee Performance Appraisal, Employment, Female, Humans, Industry, Male, Michigan, Middle Aged, Surveys and Questionnaires, Texas, United States, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review